|
Pyrazino[1',2':1,6]pyrido[3,4-b]indole-2(1H)-hexanamide, 6-(4-bromophenyl)-3,4,6,7,12,12a-hexahydro-N-hydroxy-1,4-dioxo-, (6S,12aS)- Suppliers list
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:HDAC-IN-44
CAS:2414921-46-1
Package:50mg/RMB 19420;100mg/RMB 24625;25mg/RMB 14900
|
Pyrazino[1',2':1,6]pyrido[3,4-b]indole-2(1H)-hexanamide, 6-(4-bromophenyl)-3,4,6,7,12,12a-hexahydro-N-hydroxy-1,4-dioxo-, (6S,12aS)- manufacturers
- HDAC-IN-44
-
- $2785.00 / 50mg
-
2025-10-27
- CAS:2414921-46-1
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Pyrazino[1',2':1,6]pyrido[3,4-b]indole-2(1H)-hexanamide, 6-(4-bromophenyl)-3,4,6,7,12,12a-hexahydro-N-hydroxy-1,4-dioxo-, (6S,12aS)- Basic information |
| Product Name: | Pyrazino[1',2':1,6]pyrido[3,4-b]indole-2(1H)-hexanamide, 6-(4-bromophenyl)-3,4,6,7,12,12a-hexahydro-N-hydroxy-1,4-dioxo-, (6S,12aS)- | | Synonyms: | Pyrazino[1',2':1,6]pyrido[3,4-b]indole-2(1H)-hexanamide, 6-(4-bromophenyl)-3,4,6,7,12,12a-hexahydro-N-hydroxy-1,4-dioxo-, (6S,12aS)-;HDAC-IN-44 | | CAS: | 2414921-46-1 | | MF: | C26H27BrN4O4 | | MW: | 539.42 | | EINECS: | | | Product Categories: | | | Mol File: | 2414921-46-1.mol | ![Pyrazino[1',2':1,6]pyrido[3,4-b]indole-2(1H)-hexanamide, 6-(4-bromophenyl)-3,4,6,7,12,12a-hexahydro-N-hydroxy-1,4-dioxo-, (6S,12aS)- Structure](CAS/20210305/GIF/2414921-46-1.gif) |
| | Pyrazino[1',2':1,6]pyrido[3,4-b]indole-2(1H)-hexanamide, 6-(4-bromophenyl)-3,4,6,7,12,12a-hexahydro-N-hydroxy-1,4-dioxo-, (6S,12aS)- Chemical Properties |
| density | 1.57±0.1 g/cm3(Predicted) | | pka | 9.46±0.20(Predicted) |
| | Pyrazino[1',2':1,6]pyrido[3,4-b]indole-2(1H)-hexanamide, 6-(4-bromophenyl)-3,4,6,7,12,12a-hexahydro-N-hydroxy-1,4-dioxo-, (6S,12aS)- Usage And Synthesis |
| Uses | HDAC-IN-44 is a HDAC inhibitor with the IC50 value of 61.2 nM. HDAC-IN-44 shows high anticancer activity towards multiple cancer cell lines[1]. | | References | [1] Ahmed K ElHady et al. Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors. Bioorg Chem. 2020 May;98:103742. DOI:10.1016/j.bioorg.2020.103742 |
| | Pyrazino[1',2':1,6]pyrido[3,4-b]indole-2(1H)-hexanamide, 6-(4-bromophenyl)-3,4,6,7,12,12a-hexahydro-N-hydroxy-1,4-dioxo-, (6S,12aS)- Preparation Products And Raw materials |
|